FDA recall Z-1903-2025

Luminex Corporation · Class II · device

Product

VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagnostic test

Reason for recall

It was determined that the consumable issue may result in No Call - INT CTL 1 and/or False Negative results on a small portion of the lot of test cartridges.

Distribution

US Nationwide distribution in the states of AL, CA, MN, TX, AZ, NJ, WA, SC, VA, GA, VT, CT, MD.

Key facts

Status
Completed
Initiation date
2025-04-16
Report date
2025-06-11
Voluntary/Mandated
Voluntary: Firm initiated
Location
Northbrook, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1903-2025